April CHMP Meeting: Disappointment In Advance For AB Science, Gilead Hopeful On Biktarvy

 
• By Maureen Kenny

The European Medicines Agency’s CHMP is deciding the fate of several new drugs at its April meeting, which is taking place this week.  

3d different tablets and pills on a white background with question marks
Which new drugs will the EMA recommend for approval this week? • Source: Shutterstock

More from Product Reviews

More from Pink Sheet